Cognitive decline after stroke: Relation to inflammatory biomarkers and hippocampal volume

Stroke

Volumn 44, Issue 5, 2013, Pages 1433-1435

  Kliper, Efrat ^a,b   Bashat, Dafna Ben ^a   Bornstein, Natan M ^a,b   Shenhar Tsarfaty, Shani ^a   Hallevi, Hen ^a   Auriel, Eitan ^a,b   Shopin, Ludmila ^a   Bloch, Sivan ^a,b   Berliner, Shlomo ^a   Giladi, Nir ^a,b   Goldbourt, Uri ^b   Shapira, Itzhak ^a,b   Korczyn, Amos D ^b   Assayag, Einor Ben ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

erythrocyte sedimentation rate; hippocampus; inflammation; poststroke cognitive performance

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ARTICLE; BRAIN SIZE; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE DEFECT; DEPTH PERCEPTION; ERYTHROCYTE SEDIMENTATION RATE; EXECUTIVE FUNCTION; HIPPOCAMPUS; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MEMORY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ATROPHY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COGNITION DISORDERS; FEMALE; HIPPOCAMPUS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; ORGAN SIZE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84876871720     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.000536     Document Type: Article

References (12)

1. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinfam-matory cytokine IL-6. Proc Natl Acad Sci USA. 2003;100:9090-9095.
2. Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol. 2009;66:300-305.
3. Eikelenboom P, van Exel E, Hoozemans JJ, Veerhuis R, Rozemuller AJ, van Gool WA. Neuroinfammation-an early event in both the history and pathogenesis of Alzheimer's disease. Neurodegener Dis. 2010;7:38-41.
4. Rothenburg LS, Herrmann N, Swardfager W, Black SE, Tennen G, Kiss A, et al. The relationship between infammatory markers and post stroke cognitive impairment. J Geriatr Psychiatry Neurol. 2010;23:199-205.
5. Drake C, Boutin H, Jones MS, Denes A, McColl BW, Selvarajah JR, et al. Brain infammation is induced by co-morbidities and risk factors for stroke. Brain Behav Immun. 2011;25:1113-1122.
6. Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev. 1998;105:83-107.
7. Van Wagoner NJ, Benveniste EN. Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol. 1999;100:124-139.
8. Ben Assayag E, Korczyn AD, Giladi N, Goldbourt U, Berliner AS, Shenhar-Tsarfaty S, et al. Predictors for poststroke outcomes: the Tel Aviv Brain Acute Stroke Cohort (TABASCO) study protocol. Int J Stroke. 2012;7:341-347.
9. Doniger GM, Dwolatzky T, Zucker DM, Chertkow H, Crystal H, Schweiger A, et al. Computerized cognitive testing battery identifes mild cognitive impairment and mild dementia even in the presence of depressive symptoms. Am J Alzheimers Dis Other Demen. 2006;21:28-36.
10. Karlsson H, Ahlborg B, Dalman C, Hemmingsson T. Association between erythrocyte sedimentation rate and IQ in Swedish males aged 18-20. Brain Behav Immun. 2010;24:868-873.
11. van Leeuwen MA, van Rijswijk MH. Acute phase proteins in the monitoring of infammatory disorders. Baillieres Clin Rheumatol. 1994;8:531-552.
12. Pendlebury ST, Rothwell PM. Risk of recurrent stroke, other vascular events and dementia after transient ischaemic attack and stroke. Cerebrovasc Dis. 2009;27(Suppl 3):1-11.